Alzamend Neuro
ALZN
ALZN
20 hedge funds and large institutions have $4.01M invested in Alzamend Neuro in 2022 Q1 according to their latest regulatory filings, with 10 funds opening new positions, 4 increasing their positions, 5 reducing their positions, and 9 closing their positions.
New
Increased
Maintained
Reduced
Closed
more capital invested
Capital invested by funds: $ → $
more call options, than puts
Call options by funds: $ | Put options by funds: $
more first-time investments, than exits
New positions opened: | Existing positions closed:
more funds holding
Funds holding: →
0% more ownership
Funds ownership: 0% → 0% (+0%)
20% less repeat investments, than reductions
Existing positions increased: 4 | Existing positions reduced: 5
Holders
20
Holding in Top 10
–
Calls
$264K
Puts
$113K
Top Buyers
| 1 | +$2.85M | |
| 2 | +$308K | |
| 3 | +$158K | |
| 4 |
Qube Research & Technologies (QRT)
London,
United Kingdom
|
+$97K |
| 5 |
CSS
Cubist Systematic Strategies
Stamford,
Connecticut
|
+$47K |
Top Sellers
| 1 | -$175K | |
| 2 | -$123K | |
| 3 | -$95K | |
| 4 |
EGM
Engineers Gate Manager
New York
|
-$83K |
| 5 |
Group One Trading
Chicago,
Illinois
|
-$82K |